Review

Published on 25 Jul 2024

The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease

in Neuropharmacology

Kassandra A. Zachos
Jann Aldrin Gamboa
Aleena S. Dewji
Jocelyn Lee
Sonya Brijbassi
Ana C. Andreazza

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428242

2,006 views

Review

Published on 25 Jul 2024

Nanocarrier drug delivery system: promising platform for targeted depression therapy

in Neuropharmacology

Xiaoying Feng
Ping Jia
Dingding Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1435133

2,105 views
2 citations

Review

Published on 24 Jul 2024

Supportive care of female hormones in brain health: what and how?

in Neuropharmacology

Afang Zhu
Shujia Song
Lijian Pei
Yuguang Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403969

1,789 views

Original Research

Published on 23 Jul 2024

Hyperglycemia-independent neonatal streptozotocin-induced retinopathy (NSIR) in rats

in Neuropharmacology

Yu Lin
Wenyu Du
Xiangyu Fu
Ling Huang
Yiwen Hong
Haishan Tan
Lirong Xiao
Xiang Ren
Yujiao Wang
Danian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1395887

1,476 views

Systematic Review

Published on 23 Jul 2024

NMDA antagonist agents for the treatment of symptoms in autism spectrum disorder: a systematic review and meta-analysis

in Neuropharmacology

Marie-Lou Dessus-Gilbert
Mikail Nourredine
Luc Zimmer
Benjamin Rolland
Marie-Maude Geoffray
Marine Auffret
Lucie Jurek

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1395867

1,570 views

Brief Research Report

Published on 22 Jul 2024

Wnt/β-catenin pathway as a potential target for Parkinson’s disease: a cohort study of romosozumab using routinely collected health data in Japan

in Neuropharmacology

Shoichiro Inokuchi
Koji Shimamoto

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411285

1,327 views

Original Research

Published on 19 Jul 2024

Melatonin modulates TLR4/MyD88/NF-κB signaling pathway to ameliorate cognitive impairment in sleep-deprived rats

in Neuropharmacology

Chao Yin
Meiya Zhang
Li Cheng
Li Ding
Qing Lv
Zixuan Huang
Jiaqi Zhou
Jianmei Chen
Ping Wang
Shunbo Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430599

2,125 views

Case Report

Published on 18 Jul 2024

Case report: Dezocine’s rapid and sustained antidepressant effects

in Neuropharmacology

Han Wang
Nan Lyu
Qian Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411119

897 views

Original Research

Published on 18 Jul 2024

Phosphodiesterase 7 inhibitor reduces stress-induced behavioral and cytoarchitectural changes in C57BL/6J mice by activating the BDNF/TrkB pathway

in Neuropharmacology

Jiahao Dong
Ran Wei
Fangjiao Zong
Zhe Wang
Shengyao Ma
Wei Zhao
Yuanyuan Lin
Aixin Zhang
Ge Lan
Fang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411652

908 views

Original Research

Published on 17 Jul 2024

Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023

in Neuropharmacology

Yihan Yang
Sheng Wei
Huan Tian
Jing Cheng
Yue Zhong
Xiaoling Zhong
Dunbing Huang
Cai Jiang
Xiaohua Ke

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439115

2,683 views
1 citation

Systematic Review

Published on 17 Jul 2024

Locomotion changes in methamphetamine and amphetamine withdrawal: a systematic review

in Neuropharmacology

Jaya Kumar
Isa Naina Mohamed
Rashidi Mohamed
Azizah Ugusman
Mustapha Muzaimi
Wael Mohamed
Mohamad Fairuz Yahaya
Seong Lin Teoh
Mohammad Rahim Kamaluddin
Hafizah Abdul Hamid

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428492

1,204 views

Review

Published on 16 Jul 2024

The multifaceted effects of fluoxetine treatment on cognitive functions

in Neuropharmacology

Estíbaliz Ampuero
Alejandro Luarte
Francisca Sofia Flores
Antonia Ignacia Soto
Catalina Pino
Viviana Silva
Macarena Erlandsen
Teresita Concha
Ursula Wyneken

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412420

4,894 views
1 citation

Editorial

Published on 15 Jul 2024

Editorial: Targeting mitochondrial dysfunction for the diagnosis and treatment of Alzheimer’s and cognitive-related diseases

in Neuropharmacology

Manos C. Vlasiou
Lefteris C. Zacharia
Eleni Douni
Christos Papaneophytou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1455646

610 views

Original Research

Published on 12 Jul 2024

Neuroprotective effects of total phenolics from Hemerocallis citrina Baroni leaves through the PI3K/AKT pathway

in Neuropharmacology

Yanjun Jia
Yanping Wang
Zixia Wang
Zeyu Zhang
Ju Zhang
Jingjing Zhang
Ke Sun
Yongchen Hua
Guolin Chai
Fangdi Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1370619

1,441 views
1 citation

Review

Published on 11 Jul 2024

Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs

in Neuropharmacology

Yanxin Shen
Meng Zhao
Panpan Zhao
Lingjie Meng
Yan Zhang
Guimei Zhang
Yezi Taishi
Li Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1408462

3,182 views
2 citations

Original Research

Published on 10 Jul 2024

Brozopine ameliorates cognitive impairment via upregulating Nrf2, antioxidation and anti-inflammation activities

in Neuropharmacology

Zhenzhen Fu
Xuening Wang
Yanan Fan
Dong Shang
Jiahua Zhang
Tingting Xiao
Jiajun Guo
Yi Wang
Zhiyu Wang
Zixin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428455

1,351 views

Navigation group

Articles

The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease

Nanocarrier drug delivery system: promising platform for targeted depression therapy

Supportive care of female hormones in brain health: what and how?

Hyperglycemia-independent neonatal streptozotocin-induced retinopathy (NSIR) in rats

NMDA antagonist agents for the treatment of symptoms in autism spectrum disorder: a systematic review and meta-analysis

Wnt/β-catenin pathway as a potential target for Parkinson’s disease: a cohort study of romosozumab using routinely collected health data in Japan

Melatonin modulates TLR4/MyD88/NF-κB signaling pathway to ameliorate cognitive impairment in sleep-deprived rats

Case report: Dezocine’s rapid and sustained antidepressant effects

Phosphodiesterase 7 inhibitor reduces stress-induced behavioral and cytoarchitectural changes in C57BL/6J mice by activating the BDNF/TrkB pathway

Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023

Locomotion changes in methamphetamine and amphetamine withdrawal: a systematic review

The multifaceted effects of fluoxetine treatment on cognitive functions

Editorial: Targeting mitochondrial dysfunction for the diagnosis and treatment of Alzheimer’s and cognitive-related diseases

Neuroprotective effects of total phenolics from Hemerocallis citrina Baroni leaves through the PI3K/AKT pathway

Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs

Brozopine ameliorates cognitive impairment via upregulating Nrf2, antioxidation and anti-inflammation activities